ADVANCED SOLID TUMOURS
Clinical trials for ADVANCED SOLID TUMOURS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMOURS trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMOURS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radioactive cancer drug trial halted early
Disease control TerminatedThis study tested a radioactive drug called [225Ac]-FPI-1434 in people with advanced solid tumours that had not responded to standard treatments. The goal was to find a safe dose and see if it could shrink tumours. The trial was stopped early, so results are limited. Participants…
Matched conditions: ADVANCED SOLID TUMOURS
Phase: PHASE1 • Sponsor: Fusion Pharmaceuticals Inc. • Aim: Disease control
Last updated May 26, 2026 05:06 UTC
-
Experimental KRAS drug trial halted early – what we know
Disease control TerminatedThis early-stage trial tested a new drug called AZD0022 in 17 people with advanced solid tumors (like lung, pancreatic, or colorectal cancer) that have a specific KRASG12D mutation. The study was stopped early, but researchers were checking if the drug is safe and shrinks tumors …
Matched conditions: ADVANCED SOLID TUMOURS
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 18, 2026 12:09 UTC
-
Cancer drug interaction study halted after just one participant
Knowledge-focused TerminatedThis early-stage study aimed to see if a drug called ceralasertib changes how the body processes three other cancer drugs (Drug X, Y, and Z) in people with advanced solid tumours. Only one person took part before the study was stopped early. The main goal was to measure drug leve…
Matched conditions: ADVANCED SOLID TUMOURS
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 26, 2026 05:05 UTC